Overview

Thrombolysis in Pediatric Stroke (TIPS)

Status:
Terminated
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
Thrombolysis in Pediatric Stroke (TIPS) is a five-year multi-center international safety and dose-finding study of intravenous (IV) tPA in children with acute ischemic stroke (AIS) to determine the maximal safe dose of intravenous Tissue Plasminogen Activator (IV-tPA) among three doses (0.75. 0.9, 1.0 mg/kg) for children age 2-17 years within 4.5 hours from onset of acute AIS.
Phase:
Phase 1
Details
Lead Sponsor:
Seattle Children's Hospital
Collaborators:
Alberta Children's Hospital
McMaster University
Medical College of Wisconsin
The Hospital for Sick Children
University of Texas at Austin
Treatments:
Plasminogen
Tissue Plasminogen Activator